Tickertape - Financial freedom begins here

NIIT announced the launch of its new program - Building Agentic AI Systems. This hands-on, industry-aligned program prepares engineers and professionals to design, build, secure, and operate autonomous, goal driven AI agents. The program is open to developers proficient in any modern programming stack such as Python, Java, JavaScript, or .NET(C#). It offers an immersive learning experience with real-world problems. This new initiative marks a major step in NIIT's mission to bridge the widening gap between industry demand and available AI engineering talent, empowering Indian engineering professionals to lead the next phase of AI led enterprise automation. As artificial intelligence moves beyond text generation toward systems capable of reasoning, planning, and acting autonomously, global industry leaders are calling this the next transformative leap in software development. According to McKinsey, generative AI has the potential to unlock $2.6 trillion to $4.4 trillion in additional value on top of the value potential of traditional analytical AI, with agentic systems accounting for a significant portion of that potential. Powered by Capital Market - Live

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Imitrex STATdose System, 4 mg/0.5 mL and 6 mg/0.5 mL, of GlaxoSmithKline Intellectual Property Ltd. England. Sumatriptan injection is indicated in adults for (1) the acute treatment of migraine, with or without aura, and (2) the acute treatment of cluster headache. Refer label for a detailed indication. This is Alembic's first drug device combination product. Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System, have an estimated market size of US$ 73 million for twelve months ending September 2025 according to IQVIA.Powered by Capital Market - Live

Ram Ratna Wires announced that its Bhiwadi plant has been approved under the Rajasthan Investment Promotion Scheme (RIPS-2024). This approval entitles the company to receive Turnover Linked Incentive of 1.32% (in % of EFCI), along with Electricity Duty Exemption for 7 years and 25% Stamp Duty Reimbursement. The Bhiwadi facility is expected to become a major growth driver for the company, strengthening Ram Ratna Wires' manufacturing capabilities and enabling us to serve high-demand markets more efficiently. With an approved Eligible Fixed Capital Investment (EFCI) of Rs 186.77 crore under RIPS-2024, the plant will benefit from fiscal incentives that enhance operational efficiency and cost competitiveness, contributing to profitability and reinforcing our leadership position in the industry.Powered by Capital Market - Live

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Olaparib Tablets, 100 mg and 150 mg (USRLD: Lynparza Tablets, 100 mg and 150 mg). Olaparib is indicated for treatment of certain types of ovarian, breast, pancreatic, and prostate cancers in patients who have specific genetic mutations (specifically in the BRCA gene or other homologous recombination repair [HRR] genes). Olaparib tablets will be produced at Zydus Lifesciences Ltd, SEZ. Olaparib tablets had annual sales of USD 1,379.4 mn in the United States (IQVIA MAT Sept-2025). Powered by Capital Market - Live

Lemon Tree Hotels launched its latest managed property, Lemon Tree Premier, Thiruvananthapuram. This launch marks another milestone in the brand's expansion across southern India and further reinforces its presence in Kerala, where it has five operational properties. The hotel is located in Thiruvananthapuram, also known as Trivandrum, the capital city of Kerala. On the southwest coast of India, along the Arabian Sea coast, the city has a rich history, dating back to ancient times, and it serves as an important cultural, political, and educational centre in Kerala. It is famous for its rich cultural heritage, iconic Padmanabhaswamy Temple, and scenic beaches like Kovalam. It's also a growing IT hub with Technopark and home to renowned educational and research institutions, blending tradition with modernity.Powered by Capital Market - Live

Virtuoso Optoelectronics has allotted 5,86,081 equity shares on conversion of 5,86,081 warrants to Malabar India Fund (non-promoter) on 07 November 2025. With this allotment, the paid up equity share capital has increased to 3,09,53,958 equity shares of Rs 10 each. Further, the post allotment shareholding of Malabar India Fund has increased from 2.89% to 4.73% of the total issued capital of Virtuoso Optoelectronics. Powered by Capital Market - Live

Himadri Speciality Chemical has allotted 1,00,17,200 equity shares of face value of Re 1 each upon conversion of equivalent number of warrants on 07 November 2025. Consequently, the issued and paid up capital of the Company stands increased to Rs. 50,44,94,950/- consisting of 50,44,94,950 equity shares of Re. 1/- each. Powered by Capital Market - Live

Lloyds Engineering Works has granted 3,20,000 stock options to the employees of Techno Industries, subsidiary of the Company under the ''Lloyds Steels Industries Limited Employee Stock Option Plan - 2021'. Powered by Capital Market - Live

Lloyds Engineering Works has allotted 1,05,784 equity shares under ESOP on 07 November 2025. Powered by Capital Market - Live

PB Fintech has allotted 6,17,833 equity shares under ESOP on 07 November 2025. With this allotment, the paid up equity share capital has increased to Rs. 92,39,96,216/- consisting of 46,19,98,108 equity shares having a face value of Rs. 2/- each. Powered by Capital Market - Live